Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2026-01-01 @ 2:08 PM
Study NCT ID:
NCT06835569
Status:
RECRUITING
Last Update Posted:
2025-12-10
First Post:
2025-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Sponsor:
Alterome Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | KRAS mutation | View |
| None | NSCLC | View |
| None | Non-small cell lung cancer | View |
| None | Colorectal cancer | View |
| None | Pancreatic ductal adenocarcinoma | View |
| None | Colorectal carcinoma | View |
| None | Pancreatic cancer | View |
| None | Pancreatic carcinoma | View |
| None | Solid tumors | View |
| None | KRAS | View |
| None | Mutation | View |
| None | Metastatic | View |
| None | Advanced unresectable | View |
| None | Neoplasms | View |
| None | Neoplasms by Site | View |
| None | Carcinoma | View |
| None | Non-small cell lung carcinoma | View |
| None | Non-small cell lung neoplasm | View |
| None | Pancreatic neoplasm | View |
| None | Lung neoplasm | View |
| None | Colorectal neoplasm | View |
| None | Colon neoplasm | View |
| None | Mutant KRAS | View |
| None | KRAS amplification | View |